CLINICAL_TRIALS
research
· 2025-02-06
Clinical Trial Update: Phase II Clinical Study of Contezolid for the Treatment of Bone and Joint Tuberculosis [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial evaluating contezolid for bone and joint tuberculosis is currently enrolling at Beijing Chest Hospital.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beijing Chest Hospital | Conditions: Tuberculosis, Bone | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION